Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effects of Ultrasound Therapy in Iliotibial Band Syndrome

NCT: NCT07534605 · COMPLETED

NCT IDNCT07534605
StatusCOMPLETED
Start Date2025-06-15
Completion2025-11-19

Brief Summary

The aim of this study is to investigate the effect of ultrasound (US) therapy, administered in different modes, on pain, functionality, quality of life and iliotibial band (ITB) thickness in patients with iliotibial band syndrome (ITBS). The primary question of the study is: Is US therapy effective in reducing pain and improving functionality in ITBS? The secondary question is: Is US therapy effective in ITBS in terms of quality of life and ITB thickness? 75 participants were assigned to the exercise, exercise plus continuous US and exercise plus intermittent US groups and received 15 treatment sessions. Participants were assessed before treatment, at the end of treatment (after 15 sessions) and at 3 months post-treatment.

Frequently Asked Questions

What is Effects of Ultrasound Therapy in Iliotibial Band Syndrome?

Effects of Ultrasound Therapy in Iliotibial Band Syndrome is a clinical trial registered under NCT07534605. Current status: COMPLETED.

What is the status of NCT07534605?

The current status of NCT07534605 (Effects of Ultrasound Therapy in Iliotibial Band Syndrome) is: COMPLETED.

When did Effects of Ultrasound Therapy in Iliotibial Band Syndrome start?

Effects of Ultrasound Therapy in Iliotibial Band Syndrome started on 2025-06-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.